NCATS RFI: early identification for gene-targeted therapies

NCATS is soliciting input on identifying challenges related to the early identification of individuals who could potentially benefit from gene-targeted therapies and the roadblocks to the equitable and timely delivery of such therapies to them.

This RFI invites stakeholders throughout the scientific research, advocacy, clinical practice, industry, patient and lay communities, including the general public, to comment on the following areas related to the effective, efficient and equitable distribution of gene-targeted therapies.

The due date for responses is May 31, 2021.

For more information about this RFI, visit grants.nih.gov.